RESEARCH-USE BIOSIMILAR ANTIBODY
Abituzumab
Monoclonal antibody · IgG2
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer.
TARGETITGAV
YMonoclonal antibody
CATALOGSC-BS-784
CATALOG NUMBERSC-BS-784
MOLECULAR WEIGHTApprox. 144.58 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Abituzumab (DI17E6) is a humanised anti-integrin αV monoclonal antibody (IgG2 type). Abituzumab effectively reduces the phosphorylation of FAK, Akt and ERK. Abituzumab can be used in cancer research, particularly in prostate cancer.
Abituzumab is a recombinant research-use antibody directed against ITGAV.